Director Ronald Richard Sells Common Shares of Emergent BioSolutions Inc

Gilead Foundation Awards Over $3 Million to Support People Living With Metastatic Breast Cancer

Barclays Initiates Viatris at Overweight With $15 Price Target

Tonix Pharmaceuticals Names Irina Ishak General Counsel

Tonix Pharmaceuticals Appoints Irina Ishak as General Counsel

Gilead Unit Reports Encouraging Phase 1 Data Showing High Response Rates for Bicistronic CAR T-Cell Candidates in B-Cell Lymphoma

Arcellx Says Phase 2 Cancer Study Shows 96% Overall Response Rate; Shares Up Pre-Bell

Viatris to Sell its Equity Stake in Biocon Biologics for $815 Million

Gilead's Yescarta Shows Consistent Benefits in Relapsed Large B-cell Lymphoma in New Study

BRIEF-Kite Announces New Data For Pivotal Immagine-1 Study At Ash 2025, Highlighting Anito-Cel’S Opportunity In Relapsed Or Refractory Multiple Myeloma

Gilead’s Kite Reports Promising Phase 1 Results for Next-Gen CAR T-Cell Therapies in B-Cell Lymphoma

Viatris Inc - Viatris to Receive $400 Mln in Cash and $415 Mln in Equity Shares of Biocon Limited

Press Release: Viatris Announces Agreement to Monetize its Equity Stake in Biocon Biologics Limited

Biocon fully integrates Biocon Biologics in $5.5 billion deal

Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Viatris Appoints David Simmons to Board Committees After Annual Meeting

BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EST on 2025-12-05

BRIEF-Aethlon Medical Announces Pricing Of A Private Placement And Warrant Inducement